CD39+ Tregs suppress IL-2 production in CD4+ T cells through the CD39/A2AR/cAMP pathway, and a high frequency of CD39+ Tregs correlates with poor clinical outcomes in HIV infection [221]. Here, CD4 is linked to HIV infectious disease.